Literature DB >> 20696467

Cellular origin of platelet-derived microparticles in vivo.

Andreas Rank1, Rienk Nieuwland, Ruth Delker, Anton Köhler, Bettina Toth, Verena Pihusch, Ralf Wilkowski, Rudolf Pihusch.   

Abstract

INTRODUCTION: Microparticles (MP), presumably of platelet origin, are the most abundant microparticles in blood. To which extent such MP may also directly originate from megakaryocytes, however, is unknown. During hematopoietic stem cell transplantation, patients undergo total body irradiation which leads to an irreversible destruction of hematopoiesis.
MATERIAL AND METHODS: We studied the levels of "platelet-derived" MP (PMP) in 13 patients before and after total body irradiation with 12 Gy (4 Gy for 3 days, dose rate 4.5 cGy/min). PMP were isolated and double-stained with annexin V and anti-CD61. In 6 patients, we additionally analyzed MP exposing P-selectin or CD63.
RESULTS: PMP rapidly declined upon total body irradiation, which was 2.4-fold faster than platelet disappearance. In contrast, the kinetics of MP exposing P-selectin or CD63 was comparable to platelets.
CONCLUSIONS: Since CD61-positive MP disappear faster than platelets or MP exposing P-selectin or CD63, our data indicate that MP exposing P-selectin or CD63 are likely to originate from platelets, whereas at least a major fraction of CD61-exposing MP is likely to originate from megakaryocytes in vivo.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20696467     DOI: 10.1016/j.thromres.2010.07.012

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  10 in total

1.  CLEC-2 expression is maintained on activated platelets and on platelet microparticles.

Authors:  Eelo Gitz; Alice Y Pollitt; Jerney J Gitz-Francois; Osama Alshehri; Jun Mori; Samantha Montague; Gerard B Nash; Michael R Douglas; Elizabeth E Gardiner; Robert K Andrews; Christopher D Buckley; Paul Harrison; Steve P Watson
Journal:  Blood       Date:  2014-08-22       Impact factor: 22.113

2.  P2Y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets.

Authors:  Aleksandra Gasecka; Rienk Nieuwland; Edwin van der Pol; Najat Hajji; Agata Ćwiek; Kinga Pluta; Michał Konwerski; Krzysztof J Filipiak
Journal:  Cardiol J       Date:  2018-04-19       Impact factor: 2.737

3.  Platelets are efficient and protective depots for storage, distribution, and delivery of lysosomal enzyme in mice with Hurler syndrome.

Authors:  Mei Dai; Jingfen Han; Salim S El-Amouri; Roscoe O Brady; Dao Pan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

4.  Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel.

Authors:  Aleksandra Gasecka; Rienk Nieuwland; Monika Budnik; Françoise Dignat-George; Ceren Eyileten; Paul Harrison; Romaric Lacroix; Aurélie Leroyer; Grzegorz Opolski; Kinga Pluta; Edwin van der Pol; Marek Postuła; Pia Siljander; Jolanta M Siller-Matula; Krzysztof J Filipiak
Journal:  J Thromb Haemost       Date:  2020-01-09       Impact factor: 5.824

Review 5.  Role of Platelet-Derived Microvesicles As Crosstalk Mediators in Atherothrombosis and Future Pharmacology Targets: A Link between Inflammation, Atherosclerosis, and Thrombosis.

Authors:  Lina Badimon; Rosa Suades; Eduardo Fuentes; Iván Palomo; Teresa Padró
Journal:  Front Pharmacol       Date:  2016-08-31       Impact factor: 5.810

6.  Human platelet interaction with E. coli O111 promotes tissue-factor-dependent procoagulant activity, involving Toll like receptor 4.

Authors:  Valeria Matus; J Guillermo Valenzuela; Patricia Hidalgo; L María Pozo; Olga Panes; Aniela Wozniak; Diego Mezzano; Jaime Pereira; Claudia G Sáez
Journal:  PLoS One       Date:  2017-09-28       Impact factor: 3.240

Review 7.  Platelets Extracellular Vesicles as Regulators of Cancer Progression-An Updated Perspective.

Authors:  Magdalena Żmigrodzka; Olga Witkowska-Piłaszewicz; Anna Winnicka
Journal:  Int J Mol Sci       Date:  2020-07-22       Impact factor: 5.923

Review 8.  Circulating microparticles: square the circle.

Authors:  Natasha S Barteneva; Elizaveta Fasler-Kan; Michael Bernimoulin; Joel N H Stern; Eugeny D Ponomarev; Larry Duckett; Ivan A Vorobjev
Journal:  BMC Cell Biol       Date:  2013-04-22       Impact factor: 4.241

9.  Phospholipid Binding Protein C Inhibitor (PCI) Is Present on Microparticles Generated In Vitro and In Vivo.

Authors:  Katrin Einfinger; Sigrun Badrnya; Margareta Furtmüller; Daniela Handschuh; Herbert Lindner; Margarethe Geiger
Journal:  PLoS One       Date:  2015-11-18       Impact factor: 3.240

Review 10.  Extracellular Vesicles as Markers and Mediators in Sepsis.

Authors:  Pierre Raeven; Johannes Zipperle; Susanne Drechsler
Journal:  Theranostics       Date:  2018-05-23       Impact factor: 11.556

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.